Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

China flag China · Delayed Price · Currency is CNY
23.98
+0.42 (1.78%)
Mar 26, 2026, 2:25 PM CST
Market Cap12.34B +5.6%
Revenue (ttm)1.05B +15.9%
Net Income390.43M +25.0%
EPS0.75 +25.0%
Shares Out523.58M
PE Ratio31.59
Forward PE30.60
Dividend0.22 (0.93%)
Ex-Dividend DateJan 20, 2026
Volume14,698,259
Average Volume9,363,034
Open25.53
Previous Close23.56
Day's Range23.50 - 25.53
52-Week Range18.60 - 35.84
Beta0.60
RSI32.94
Earnings DateApr 24, 2026

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 a... [Read more]

Sector Healthcare
Founded 2002
Employees 1,679
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300357
Full Company Profile

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.

Financial Statements